Technical Analysis for MEM - Memphasys Ltd
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Flat |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Calm After Storm | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Earnings Movers | Other | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Calm After Storm | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Calm After Storm | Range Contraction | -16.67% | |
| Narrow Range Bar | Range Contraction | -16.67% |
| Alert | Time |
|---|---|
| Rose Above 10 DMA | about 8 hours ago |
| 2x Volume Pace | about 8 hours ago |
| 1.5x Volume Pace | about 8 hours ago |
| Fell Below 10 DMA | about 8 hours ago |
| 1.5x Volume Pace | 1 day ago |
Get this analysis on your stocks daily!
Memphasys Ltd Description
Memphasys Limited, formerly NuSep Holdings Limited, is a bio-separations company developing and commercializing separation techniques based on its membrane technology. The Company has two main areas of focus for separating biological substances from fluids, utilizing its separation membranes and equipment: SpermSep and Hydrogel polymer membrane technology development. Its segments include Separations and Corporate. The Separations segment develops and markets the PrIME technology in both the commercial and research markets, including the ProteomeSep and SpermSep devices. Its program, SpermSep, separates the sperm from a semen sample using electrophoresis and specialist membranes. The SpermSep technology is used in fertility treatments, including in vitro fertilization (IVF) for humans and in various artificial reproductive techniques (ART) for animals. It has developed a polymer membrane separation technology using polyacrylamide hydrogel membranes with electrophoresis.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Chemistry Natural Sciences Biotechnology Flu Animals Filtration In Vitro Membrane Membrane Technology Technology Development Fertility Humans Assisted Reproductive Technology Fertility Medicine In Vitro Fertilisation In Vitro Fertilization
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Date | Title |
|---|---|
| Sep 1 | Memphasys Reports Full Year 2024 Earnings |
| Indicator | Value |
|---|---|
| 52 Week High | 0.017 |
| 52 Week Low | 0.004 |
| Average Volume | 1,586,349 |
| 200-Day Moving Average | 0.009 |
| 50-Day Moving Average | 0.007 |
| 20-Day Moving Average | 0.006 |
| 10-Day Moving Average | 0.005 |
| Average True Range | 0.001 |
| RSI (14) | 50.00 |
| ADX | 20.68 |
| +DI | 34.444 |
| -DI | 43.333 |
| Chandelier Exit (Long, 3 ATRs) | 0.006 |
| Chandelier Exit (Short, 3 ATRs) | 0.006 |
| Upper Bollinger Bands | 0.008 |
| Lower Bollinger Band | 0.004 |
| Percent B (%b) | 0.29 |
| BandWidth | 80.000 |
| MACD Line | -0.001 |
| MACD Signal Line | -0.001 |
| MACD Histogram | -0.0001 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.005 | ||||
| Resistance 3 (R3) | 0.005 | 0.005 | 0.005 | ||
| Resistance 2 (R2) | 0.005 | 0.005 | 0.005 | 0.005 | |
| Resistance 1 (R1) | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 |
| Pivot Point | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 |
| Support 1 (S1) | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 |
| Support 2 (S2) | 0.005 | 0.005 | 0.005 | 0.005 | |
| Support 3 (S3) | 0.005 | 0.005 | 0.005 | ||
| Support 4 (S4) | 0.005 |
